These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4144050)

  • 1. Drugs in management of minimal brain dysfunction.
    Millichap JG
    Ann N Y Acad Sci; 1973 Feb; 205():321-34. PubMed ID: 4144050
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy in minimal brain dysfunction: a commentary.
    Erenberg G
    J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
    Millichap JG; Fowler GW
    Pediatr Clin North Am; 1967 Nov; 14(4):767-77. PubMed ID: 4875461
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperkineticism in children.
    IMJ Ill Med J; 1970 Dec; 138(6):618. PubMed ID: 4395617
    [No Abstract]   [Full Text] [Related]  

  • 5. [The minimal brain dysfunction syndrome].
    Verret S
    Vie Med Can Fr; 1973 Jul; 2(7):649-55. PubMed ID: 4760948
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs in the management of learning and behavior disorders in school children.
    Millichap JG
    IMJ Ill Med J; 1974 Apr; 145(4):322-3. PubMed ID: 4151138
    [No Abstract]   [Full Text] [Related]  

  • 7. Coping on amphetamines.
    Gordon AM
    N Engl J Med; 1970 Feb; 282(6):346. PubMed ID: 5410842
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperactivity in children.
    Lightfoot OB
    J Natl Med Assoc; 1973 Jan; 65(1):58-62. PubMed ID: 4687191
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal brain dysfunction. V. Diagnosis and treatment. B. Drug treatment. Drug therapy: initiation and follow-up.
    Solomons G
    Ann N Y Acad Sci; 1973 Feb; 205():335-44. PubMed ID: 4144051
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral medications for minimal brain dysfunction in children.
    Green RP; Scales SM; Rosser PL
    J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
    [No Abstract]   [Full Text] [Related]  

  • 11. Deanol and methylphenidate in minimal brain dysfunction.
    Lewis JA; Young R
    Clin Pharmacol Ther; 1975 May; 17(5):534-40. PubMed ID: 1092513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of antidepressants in the treatment of children with behaviour disorders.
    Huessy HR
    Can J Psychiatry; 1993 Feb; 38(1):68-9. PubMed ID: 8448727
    [No Abstract]   [Full Text] [Related]  

  • 14. Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: a double-blind comparison.
    Huestis RD; Arnold LE; Smeltzer DJ
    Am J Psychiatry; 1975 Aug; 132(8):868-70. PubMed ID: 1096645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal brain dysfunction in children. Diagnosis and management.
    Wender PH
    Pediatr Clin North Am; 1973 Feb; 20(1):187-202. PubMed ID: 4581984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychopharmaca in modern medicine].
    Vinar O
    Cesk Farm; 1968 Dec; 17(10):496-502. PubMed ID: 4388672
    [No Abstract]   [Full Text] [Related]  

  • 17. Behaviour disorders in brain-damaged children.
    Pond DA
    Mod Trends Neurol; 1967; 4(0):125-34. PubMed ID: 4950796
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric psychopharmacology. A review with special reference to deanol.
    Oettinger L
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):25-31. PubMed ID: 338271
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential response to psychotropic drugs.
    Johnson G; Gershon S
    Compr Psychiatry; 1971 Sep; 12(5):399-413. PubMed ID: 4399193
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.